Risk-based management for the prevention of GBS infection in neonates
Introduction: Group B streptococcus
(GBS) has been identified as one of the commonest causes of sepsis and meningitis in neonates leading
to increased rates in neonatal morbidity and mortality among developed countries, while being correlated with resulting
in preterm birth. At present, preventive
antibiotic regimens are administered only to these pregnant women who have been identified as having risk factors to
develop GBS infection or those with positive cultures for GBS, based on
the updated guidelines (risk-based strategy).
Methods:
One of the goals of this research was to investigate if there is any
correlation between GBS infection and
preterm delivery, through looking thoroughly in the available GBS outcomes of the maternity unit that the study took
place, as as well as to evaluate the effectiveness of current risk-based protocols compared to universal screening in the prevention of neonatal GBS disease.
Results: GBS has been shown not to be an imminent cause of preterm
delivery, a statistic that was one of
the main parameters of this study, as only 7 of the 2.753 pregnant women that were
found to have GBS positive vaginal or
rectal cultures resulted in delivering premature neonates (<37 weeks of gestational age).
Discussion: After reflecting on the results of the data of the
maternity hospital, 1237 neonates in total
have received antibiotics for suspected GBS sepsis, that was finally identified
in only 23 newborns (6 of them
premature), resulting in administrating unnecessarily chemoprophylaxis to 1214 pregnant women in total. Besides,
only 35% of pregnant women have been tested for GBS during their
antenatal period according to the data collected.
Comments
Post a Comment